Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeoGenomics Laboratories, Inc. ("NeoGenomics" or "the Company") (NASDAQ: NEO). Investors who purchased NeoGenomics securities prior to November 9, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/neo.

The investigation concerns whether NeoGenomics and certain of its officers and/or directors have engaged in corporate wrongdoing.

If you are aware of any facts relating to this investigation or purchased NeoGenomics shares prior to February 27, 2020, you can assist this investigation by visiting the firm’s site: www.bgandg.com/neo. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005832/en/